Regeneron’s Share Price Soars as New Deal with sanofi-aventis is Signed
By Business Review Editor
Pharma Deals Review: Vol 2008 Issue 91 (Table of Contents)
Published: 8 Jan-2008
DOI: 10.3833/pdr.v2008.i91.232 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Regeneron Pharmaceuticals and Sanofi-Aventis entered into research collaboration to discover, develop and commercialize human therapeutic antibodies utilizing Regeneron’s proprietary VelociSuite technologies including VelocImmune®...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS